Get report

Foxico is the most complete listing of projects that conduct ICO with the most trustworthy ICOs ratings from blockchain experts and investors. Foxico provides an in-depth project analysis helping you to make quick decision about investing!

trakinvest
bookmark7.5 /10

team - very strong team

mvp - yes 

idea - interesting 

competitors - low 

market - #medicine

Starts
Dec 8th 2017
3 months ago
Ends
Feb 28th 2018
in 3 days

The LUVEN screening test method created by the scientist of our company detects cancer at its early stages with the accuracy of up to 96% only comparable to biopsy. None of the existing diagnostic techniques has such a high diagnostic accuracy.

The LUVEN technology allows to diagnose the disease at its early stages, thus, giving a chance to thousands of people to prevent its further development.

For more than 20 years the Ukrainian scientists have been developing a diagnostic method based on cyto-morphological and cyto-biophysical properties of the buccal epithelial cells. In 2004 at Fenix Cancer Research Center, they continued their research and, finally, came up and implemented an experimental method.

A new method of biomaterial analysis allowed to establish a cancer diagnosis at its early stages and to assess predisposition to cancer .A great success in this medical field opened a door to new possibilities, including cancer prevention and therapy.

The longstanding scientific research in this field culminated in development of The Luven diagnostic system.

Team

Alexander Danilchenko
CEO
Nikolay Shchukin
Postgraduate Student of Chair for Biomedical Engineering
Aleksander Shchukin
Nuclear physicist
Galina Shchukina
Grigory Evglevskiy
CTO
Alexander Kamensky
Principal Software Engineer
Yana Ivchenko
PR Manager
Lina Lisitsa
SMO/SMM Manager

Social

Rating widget

Luven Diagnostic ICO rating